Zhou Di, Ye Ming, Bai Yongrui, Rong Ling, Hou Yanli
The Department of Radiation Oncology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Can J Surg. 2015 Aug;58(4):237-44. doi: 10.1503/cjs.001515.
The lymph node ratio (LNR) has been shown to be an important prognostic factor in patients with gastric, breast, pancreatic and colorectal cancer. We investigated the prognostic impact of the LNR in addition to TNM classification in patients with locally advanced rectal cancer.
We retrospectively analyzed patients who underwent curative resection for locally advanced rectal cancer between July 2005 and December 2010. We determined the LNR cutoff value using a receiver operating characteristic curve. The Kaplan-Meier method was used to estimate survival curves, while Cox regression analyses were used to evaluate the relationship between LNR and survival.
We included 180 patients aged 28-83 years with median follow-up of 41.8 months. The median number of lymph nodes examined and lymph nodes involved were 11.5 and 4, respectively, and the median LNR was 0.366. An LNR of 0.19 (19%) was the cutoff point to separate patients with regard to median overall survival. Median overall survival was 64.2 months for patients with an LNR of 0, 59.1 for an LNR of 0.19 or less and 37.6 for an LNR greater than 0.19 (p = 0.004). The median disease-free survival was 32.9 months for patients with an LNR of 0, 30.4 for an LNR of 0.19 or less and 17.8 for an LNR greater than 0.19 (p = 0.002).
Our results suggest that LNR should be considered an additional prognostic factor in patients with locally advanced rectal cancer.
淋巴结比率(LNR)已被证明是胃癌、乳腺癌、胰腺癌和结直肠癌患者的重要预后因素。我们研究了LNR在局部晚期直肠癌患者中除TNM分类之外的预后影响。
我们回顾性分析了2005年7月至2010年12月间接受局部晚期直肠癌根治性切除术的患者。我们使用受试者工作特征曲线确定LNR临界值。采用Kaplan-Meier方法估计生存曲线,同时使用Cox回归分析评估LNR与生存之间的关系。
我们纳入了180例年龄在28 - 83岁之间的患者,中位随访时间为41.8个月。检查的淋巴结中位数和受累淋巴结中位数分别为11.5个和4个,中位LNR为0.366。LNR为0.19(19%)是区分患者中位总生存期的临界点。LNR为0的患者中位总生存期为64.2个月,LNR为0.19或更低的患者为59.1个月,LNR大于0.19的患者为37.6个月(p = 0.004)。LNR为0的患者中位无病生存期为32.9个月,LNR为0.19或更低的患者为30.4个月,LNR大于0.19的患者为17.8个月(p = 0.002)。
我们的结果表明,LNR应被视为局部晚期直肠癌患者的一个额外预后因素。